{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T13:59:07Z","timestamp":1781963947893,"version":"3.54.5"},"reference-count":77,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2011,3,31]],"date-time":"2011-03-31T00:00:00Z","timestamp":1301529600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ann Oper Res"],"published-print":{"date-parts":[[2014,10]]},"DOI":"10.1007\/s10479-011-0869-4","type":"journal-article","created":{"date-parts":[[2011,3,30]],"date-time":"2011-03-30T07:55:02Z","timestamp":1301471702000},"page":"331-356","source":"Crossref","is-referenced-by-count":87,"title":["A survey of optimization models on cancer chemotherapy treatment planning"],"prefix":"10.1007","volume":"221","author":[{"given":"Jinghua","family":"Shi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oguzhan","family":"Alagoz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatih Safa","family":"Erenay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiang","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,3,31]]},"reference":[{"issue":"5","key":"869_CR1","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1287\/opre.1060.0320","volume":"54","author":"Z. Agur","year":"2006","unstructured":"Agur, Z., Hassin, R., & Levy, S. (2006). Optimizing chemotherapy scheduling using local search heuristics. Operations Research, 54(5), 829\u2013846.","journal-title":"Operations Research"},{"issue":"10","key":"869_CR2","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1287\/mnsc.1040.0287","volume":"50","author":"O. Alagoz","year":"2004","unstructured":"Alagoz, O., Maillart, L. M., Schaefer, A. J., & Roberts, M. S. (2004). The optimal timing of living-donor liver transplantation. Management Science, 50(10), 1420\u20131430.","journal-title":"Management Science"},{"issue":"1","key":"869_CR3","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1287\/opre.1060.0329","volume":"55","author":"O. Alagoz","year":"2007","unstructured":"Alagoz, O., Maillart, L. M., Schaefer, A. J., & Roberts, M. S. (2007a). Determining the acceptance of cadaveric livers using an implicit model of the waiting list. Operation Research, 55(1), 24\u201336.","journal-title":"Operation Research"},{"issue":"11","key":"869_CR4","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1287\/mnsc.1070.0726","volume":"53","author":"O. Alagoz","year":"2007","unstructured":"Alagoz, O., Maillart, L. M., Schaefer, A. J., & Roberts, M. S. (2007b). Choosing among living-donor and cadaveric livers. Management Science, 53(11), 1702\u20131715.","journal-title":"Management Science"},{"key":"869_CR5","unstructured":"American Cancer Society (ACS) (2001\u20132008). Cancer facts and figures 2001\u20132008. http:\/\/www.cancer.org\/docroot\/STT\/content\/STT_1x_2001_Facts_and_Figures.pdf.asp . Accessed 5 Oct 2009."},{"key":"869_CR6","unstructured":"American Cancer Society (ACS) (2009). Cancer facts and figures 2009. http:\/\/www.cancer.org\/downloads\/STT\/500809web.pdf . Accessed Apr 21 2010."},{"issue":"15","key":"869_CR7","doi-asserted-by":"crossref","first-page":"2896","DOI":"10.1200\/JCO.2003.10.065","volume":"21","author":"T. Andre","year":"2003","unstructured":"Andre, T., Colin, P., Louvet, C., Gamelin, E., Bouche, O., Achille, E. et al. (2003). Semimonthly versus monthly regimen of fluorouracil and leucovorin administered for 24 or 36 weeks as adjuvant therapy in stage II and III colon cancer: Results of a randomized trial. Journal of Clinical Oncology, 21(15), 2896\u20132903.","journal-title":"Journal of Clinical Oncology"},{"issue":"23","key":"869_CR8","doi-asserted-by":"crossref","first-page":"2343","DOI":"10.1056\/NEJMoa032709","volume":"350","author":"T. Andre","year":"2004","unstructured":"Andre, T., Boni, C., Mounedji-Boudiaf, L., Navarro, M., Tabernero, J., Hickish, T. et al. (2004). Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer. New England Journal of Medicine, 350(23), 2343\u20132351.","journal-title":"New England Journal of Medicine"},{"issue":"3","key":"869_CR9","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0010-4825(00)00032-9","volume":"31","author":"D. Barbolosi","year":"2001","unstructured":"Barbolosi, D., & Iliadis, A. (2001). Optimizing drug regimens in cancer chemotherapy: A simulation study using a PK-PD model. Computers in Biology and Medicine, 31(3), 157\u2013172.","journal-title":"Computers in Biology and Medicine"},{"key":"869_CR10","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/0025-5564(84)90061-0","volume":"72","author":"B. G. Birkhead","year":"1984","unstructured":"Birkhead, B. G., & Gregory, W. M. (1984). A mathematical model of the effects of drug resistance in cancer chemotherapy. Mathematical. Bioscience, 72, 59\u201369.","journal-title":"Bioscience"},{"key":"869_CR11","doi-asserted-by":"crossref","DOI":"10.1002\/0470868279","volume-title":"Numerical methods for ordinary differential equations","author":"J. C. Butcher","year":"2003","unstructured":"Butcher, J. C. (2003). Numerical methods for ordinary differential equations. New York: Wiley."},{"key":"869_CR12","unstructured":"CancerHelp UK (2010). Which treatment for advanced bowel cancer. http:\/\/www.cancerhelp.org.uk\/type\/bowel-cancer\/treatment\/which-treatment-for-advanced-bowel-cancer#chemo ."},{"issue":"6","key":"869_CR13","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1186\/bcr90","volume":"2","author":"S. E. Clare","year":"2000","unstructured":"Clare, S. E., Nakhlis, F., & Panetta, J. C. (2000). Molecular biology of breast metastasis: The use of mathematical models to determine relapse and to predict response to chemotherapy in breast cancer. Breast Cancer Research, 2(6), 430\u2013435.","journal-title":"Breast Cancer Research"},{"issue":"2","key":"869_CR14","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/0025-5564(83)90066-4","volume":"65","author":"A. J. Coldman","year":"1983","unstructured":"Coldman, A. J., & Goldie, J. H. (1983). A model for the resistance of tumor cells to cancer chemotherapeutic agents. Mathematical Biosciences, 65(2), 291\u2013307.","journal-title":"Mathematical Biosciences"},{"issue":"3\/4","key":"869_CR15","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/BF02459682","volume":"48","author":"A. J. Coldman","year":"1986","unstructured":"Coldman, A. J., & Goldie, J. H. (1986). A stochastic model for the origin and treatment of tumors containing drug-resistant cells. Bulletin of Mathematical Biology, 48(3\/4), 279\u2013292.","journal-title":"Bulletin of Mathematical Biology"},{"key":"869_CR16","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0025-5564(00)00045-6","volume":"168","author":"A. J. Coldman","year":"2000","unstructured":"Coldman, A. J., & Murray, J. M. (2000). Optimal control for a stochastic model of cancer chemotherapy. Mathematical Biosciences, 168, 187\u2013200.","journal-title":"Mathematical Biosciences"},{"issue":"2","key":"869_CR17","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0025-5564(85)90054-9","volume":"74","author":"A. J. Coldman","year":"1985","unstructured":"Coldman, A. J., Goldie, J. H., & Ng, V. (1985). The effect of cellular differentiation on the development of permanent drug resistance. Mathematical Biosciences, 74(2), 177\u2013198.","journal-title":"Mathematical Biosciences"},{"issue":"1","key":"869_CR18","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/0025-5564(88)90007-7","volume":"92","author":"A. J. Coldman","year":"1988","unstructured":"Coldman, A. J., Coppin, C. M. L., & Goldie, J. H. (1988). Models for dose intensity. Mathematical Biosciences, 92(1), 97\u2013113.","journal-title":"Mathematical Biosciences"},{"issue":"2","key":"869_CR19","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/BF02462001","volume":"59","author":"M. I. S. Costa","year":"1997","unstructured":"Costa, M. I. S., & Boldrini, J. L. (1997). Chemotherapeutic treatments: A study of the interplay among drug resistance, toxicity and recuperation from side effects. Bulletin of Mathematical Biology, 59(2), 205\u2013232.","journal-title":"Bulletin of Mathematical Biology"},{"issue":"1","key":"869_CR20","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.mbs.2009.08.004","volume":"222","author":"A. d\u2019Onofrio","year":"2009","unstructured":"d\u2019Onofrio, A., Ledzewicz, U., Maurer, H., & Schattler, H. (2009). On optimal delivery of combination therapy for tumors. Mathematical Biosciences, 222(1), 13\u201326.","journal-title":"Mathematical Biosciences"},{"key":"869_CR21","first-page":"3876","volume":"46","author":"R. S. Day","year":"1986","unstructured":"Day, R. S. (1986). Treatment sequencing, asymmetry, and uncertainty: Protocol strategies for combination. Cancer Research, 46, 3876\u20133885.","journal-title":"Cancer Research"},{"issue":"16","key":"869_CR22","doi-asserted-by":"crossref","first-page":"2938","DOI":"10.1200\/JCO.2000.18.16.2938","volume":"18","author":"A. Gramont de","year":"2000","unstructured":"de Gramont, A., Figer, A., Seymour, M., Homerin, M., Hmissi, A., Cassidy, J. et al. (2000). Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer. Journal of Clinical Oncology, 18(16), 2938\u20132947.","journal-title":"Journal of Clinical Oncology"},{"key":"869_CR23","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.compchemeng.2007.07.001","volume":"32","author":"P. Dua","year":"2008","unstructured":"Dua, P., Dua, V., & Pistikopoulos, E. N. (2008). Optimal delivery of chemotherapeutic agents in cancer. Computers & Chemical Engineering, 32, 99\u2013107.","journal-title":"Computers & Chemical Engineering"},{"issue":"18","key":"869_CR24","doi-asserted-by":"crossref","first-page":"4087","DOI":"10.1016\/S0009-2509(03)00234-3","volume":"58","author":"S.-S. Feng","year":"2003","unstructured":"Feng, S.-S., & Chien, S. (2003). Chemotherapeutic engineering: Application and further development of chemical engineering principles for chemotherapy of cancer and other diseases. Chemical Engineering Science, 58(18), 4087\u20134114.","journal-title":"Chemical Engineering Science"},{"key":"869_CR25","first-page":"154","volume-title":"Proceedings of the international joint conference on neural networks","author":"A. Floares","year":"2003","unstructured":"Floares, A., Floares, C., Cucu, M., & Lazar, L. (2003). Adaptive neural networks control of drug dosage regimens in cancer chemotherapy. In Proceedings of the international joint conference on neural networks, Portland (Vol. 1, pp.\u00a0154\u2013159)."},{"issue":"2","key":"869_CR26","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1006\/jtbi.2001.2459","volume":"214","author":"S. N. Gardner","year":"2002","unstructured":"Gardner, S. N. (2002). Modeling multi-drug chemotherapy: Tailoring treatment to individuals. Journal of Theoretical Biology, 214(2), 181\u2013207.","journal-title":"Journal of Theoretical Biology"},{"key":"869_CR27","first-page":"439","volume":"66","author":"J. H. Goldie","year":"1982","unstructured":"Goldie, J. H., Coldman, A. J., & Gudauskas, G. A. (1982). Rationale for the use of alternating non-cross-resistant chemotherapy. Cancer Treatment Reports, 66, 439\u2013449.","journal-title":"Cancer Treatment Reports"},{"key":"869_CR28","unstructured":"Harrold, J. M. (2005). Model-based design of cancer chemotherapy treatment schedules. Ph.D. thesis, University of Pittsburgh, Pittsburgh."},{"issue":"12","key":"869_CR29","doi-asserted-by":"crossref","first-page":"2042","DOI":"10.1016\/j.compchemeng.2009.06.005","volume":"33","author":"J. M. Harrold","year":"2009","unstructured":"Harrold, J. M., & Parker, R. S. (2009). Clinically relevant cancer chemotherapy dose scheduling via mixed-integer optimization. Computers & Chemical Engineering, 33(12), 2042\u20132054.","journal-title":"Computers & Chemical Engineering"},{"key":"869_CR30","unstructured":"Horner, M. J., Ries, L. A. G., Krapcho, M., Neyman, N., Aminou, R., & Howlader, N. (2009). Seer cancer statistics review 1975\u20132006. http:\/\/seer.cancer.gov\/csr\/1975_2006\/ . Accessed 15 Oct 2009."},{"key":"869_CR31","unstructured":"Hryniuk, W. M. (1988). The importance of dose intensity in the outcome of chemotherapy. Important Advances in Oncology, 121\u2013141."},{"issue":"3","key":"869_CR32","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1006\/cbmr.2000.1540","volume":"33","author":"A. Iliadis","year":"2000","unstructured":"Iliadis, A., & Barbolosi, D. (2000). Optimizing drug regimens in cancer chemotherapy by an efficacy-toxicity mathematical model. Computers and Biomedical Research, 33(3), 211\u2013226.","journal-title":"Computers and Biomedical Research"},{"issue":"12","key":"869_CR33","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1016\/j.na.2009.01.214","volume":"71","author":"M. Itik","year":"2009","unstructured":"Itik, M., Salamci, M. U., & Banks, S. P. (2009). Optimal control of drug therapy in cancer treatment. Nonlinear Analysis, 71(12), 1473\u20131486.","journal-title":"Nonlinear Analysis"},{"issue":"1","key":"869_CR34","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0025-5564(99)00062-0","volume":"164","author":"T. L. Jackson","year":"2000","unstructured":"Jackson, T. L., & Byrne, H. M. (2000). A mathematical model to study the effects of drug resistance and vasculature on the response of solid tumors to chemotherapy. Mathematical Biosciences, 164(1), 17\u201338.","journal-title":"Mathematical Biosciences"},{"issue":"2","key":"869_CR35","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1109\/TITB.2005.859888","volume":"10","author":"Y. Liang","year":"2006","unstructured":"Liang, Y., Leung, K.-S., & Mok, T. S. K. (2006). A novel evolutionary drug scheduling model in cancer chemotherapy. IEEE Transactions on Information Technology in Biomedicine, 10(2), 237\u2013245.","journal-title":"IEEE Transactions on Information Technology in Biomedicine"},{"issue":"6","key":"869_CR36","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1016\/0005-1098(92)90054-J","volume":"28","author":"R. B. Martin","year":"1992","unstructured":"Martin, R. B. (1992). Optimal control drug scheduling of cancer chemotherapy. Automatica, 28(6), 1113\u20131123.","journal-title":"Automatica"},{"key":"869_CR37","volume-title":"Optimal control of drug administration in cancer chemotherapy","author":"R. B. Martin","year":"1994","unstructured":"Martin, R. B., & Teo, K. L. (1994). Optimal control of drug administration in cancer chemotherapy. World Scientific: Singapore."},{"issue":"2","key":"869_CR38","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/0025-5564(90)90005-J","volume":"99","author":"R. B. Martin","year":"1990","unstructured":"Martin, R. B., Fisher, M. E., Minchin, R. F., & Teo, K. L. (1990). A mathematical model of cancer chemotherapy with an optimal selection of parameters. Mathematical Biosciences, 99(2), 205\u2013230.","journal-title":"Mathematical Biosciences"},{"issue":"2","key":"869_CR39","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/0025-5564(92)90038-X","volume":"110","author":"R. B. Martin","year":"1992","unstructured":"Martin, R. B., Fisher, M. E., Minchin, R. F., & Teo, K. L. (1992a). Optimal control of tumor size used to maximize survival time when cells are resistant to chemotherapy. Mathematical Biosciences, 110(2), 201\u2013219.","journal-title":"Mathematical Biosciences"},{"issue":"2","key":"869_CR40","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/0025-5564(92)90039-Y","volume":"110","author":"R. B. Martin","year":"1992","unstructured":"Martin, R. B., Fisher, M. E., Minchin, R. F., & Teo, K. L. (1992b). Low-intensity combination chemotherapy maximizes host survival time for tumors containing drug-resistant cells. Mathematical Biosciences, 110(2), 221\u2013252.","journal-title":"Mathematical Biosciences"},{"key":"869_CR41","first-page":"4851","volume-title":"Proceedings of the 39th IEEE conference on decision and control","author":"A. S. Matveev","year":"2000","unstructured":"Matveev, A. S., & Savkin, A. V. (2000). Optimal control applied to drug administration in cancer chemotherapy: The case of several toxicity constraints. In Proceedings of the 39th IEEE conference on decision and control (Vol. 5, pp. 4851\u20134856)."},{"issue":"2","key":"869_CR42","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1200\/JCO.2006.09.6081","volume":"25","author":"N. J. Meropol","year":"2007","unstructured":"Meropol, N. J., & Schulman, K. A. (2007). Cost of cancer care: Issues and implications. Journal of Clinical Oncology, 25(2), 180\u2013186.","journal-title":"Journal of Clinical Oncology"},{"key":"869_CR43","first-page":"3747","volume":"49","author":"B. E. Miller","year":"1989","unstructured":"Miller, B. E., Miller, F. R., & Heppner, G. H. (1989). Therapeutic perturbation of the tumor ecosystem in reconstructed heterogeneous mouse mammary tumors. Cancer Research, 49, 3747\u20133753.","journal-title":"Cancer Research"},{"issue":"1","key":"869_CR44","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/0025-5564(90)90047-3","volume":"100","author":"J. M. Murray","year":"1990","unstructured":"Murray, J. M. (1990). Some optimal control problems in cancer chemotherapy with a toxicity limit. Mathematical Biosciences, 100(1), 49\u201367.","journal-title":"Mathematical Biosciences"},{"issue":"2","key":"869_CR45","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/0025-5564(94)90011-6","volume":"123","author":"J. M. Murray","year":"1994","unstructured":"Murray, J. M. (1994). Optimal drug regimens in cancer chemotherapy for single drugs that block progression through the cell cycle. Mathematical Biosciences, 123(2), 183\u2013213.","journal-title":"Mathematical Biosciences"},{"key":"869_CR46","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1093\/imammb\/14.4.283","volume":"14","author":"J. M. Murray","year":"1997","unstructured":"Murray, J. M. (1997). The optimal scheduling of two drugs with simple resistance for a problem in cancer chemotherapy. IMA Journal of Mathematics Applied in Medicine & Biology, 14, 283\u2013303.","journal-title":"IMA Journal of Mathematics Applied in Medicine & Biology"},{"issue":"1","key":"869_CR47","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.mbs.2007.05.003","volume":"210","author":"S. Nanda","year":"2007","unstructured":"Nanda, S., Moore, H., & Lenhart, S. (2007). Optimal control of treatment in a mathematical model of chronic myelogenous leukemia. Mathematical Biosciences, 210(1), 143\u2013156.","journal-title":"Mathematical Biosciences"},{"key":"869_CR48","unstructured":"NCI\u2014National Cancer Institute (2007). Cancer trends progress report-2007 update. http:\/\/progressreport.cancer.gov\/doc_detail.asp?pid=1&did=2007&chid=75&coid=726&mid . Accessed 5 Oct 2009."},{"issue":"3","key":"869_CR49","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1007\/BF02460591","volume":"58","author":"J. C. Panetta","year":"1996","unstructured":"Panetta, J. C. (1996). A mathematical model of periodically pulsed chemotherapy: Tumor recurrence and metastasis in a competitive environment. Bulletin of Mathematical Biology, 58(3), 425\u2013447.","journal-title":"Bulletin of Mathematical Biology"},{"issue":"1","key":"869_CR50","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0025-5564(97)00080-1","volume":"147","author":"J. C. Panetta","year":"1998","unstructured":"Panetta, J. C. (1998). A mathematical model of drug resistance: Heterogeneous tumors. Mathematical Biosciences, 147(1), 41\u201361.","journal-title":"Mathematical Biosciences"},{"issue":"2","key":"869_CR51","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/0895-7177(95)00112-F","volume":"22","author":"J. C. Panetta","year":"1995","unstructured":"Panetta, J. C., & Adam, J. (1995). A mathematical model of cycle-specific chemotherapy. Mathematical and Computer Modelling, 22(2), 67\u201382.","journal-title":"Mathematical and Computer Modelling"},{"key":"869_CR52","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S0169-409X(01)00114-4","volume":"48","author":"R. S. Parker","year":"2001","unstructured":"Parker, R. S., & Doyle, F. J. (2001). Control-relevant modeling in drug delivery. Advanced Drug Delivery Reviews, 48, 211\u2013228.","journal-title":"Advanced Drug Delivery Reviews"},{"key":"869_CR53","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1109\/IEMBS.1990.691572","volume-title":"Proceedings of the twelfth annual international conference of the IEEE engineering in medicine and biology society","author":"F. L. Pereira","year":"1990","unstructured":"Pereira, F. L., Pedreira, C. E., Pinho, M. R., Fernandes, M. H., & Sousa, J. B. (1990). An optimal control algorithm for multidrug cancer chemotherapy design. In Proceedings of the twelfth annual international conference of the IEEE engineering in medicine and biology society (pp. 1021\u20131022)."},{"issue":"4","key":"869_CR54","first-page":"257","volume":"6","author":"F. L. Pereira","year":"1995","unstructured":"Pereira, F. L., Pedreira, C. E., & De Sousa, J. B. (1995). A new optimization based approach to experimental combination chemotherapy. Frontiers of Medical and Biological Engineering, 6(4), 257\u2013268.","journal-title":"Frontiers of Medical and Biological Engineering"},{"key":"869_CR55","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1007\/3-540-44719-9_37","volume":"1993\/2001","author":"A. Petrovski","year":"2001","unstructured":"Petrovski, A., & McCall, J. (2001). Multi-objective optimisation of cancer chemotherapy using evolutionary algorithms. Lecture Notes in Computer Science, 1993\/2001, 531\u2013545.","journal-title":"Lecture Notes in Computer Science"},{"key":"869_CR56","unstructured":"Petrovski, A., Shakya, S., & McCall, J. (2006). Optimising cancer chemotherapy using an estimation of distribution algorithm and genetic algorithms. Paper presented at: 8th annual conference on genetic and evolutionary computation."},{"key":"869_CR57","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1007\/978-3-540-30217-9_64","volume":"3242","author":"A. Petrovski","year":"2004","unstructured":"Petrovski, A., Sudha, B., & McCall, J. (2004). Optimising cancer chemotherapy using particle swarm optimisation and genetic algorithms. Lecture Notes in Computer Science, 3242, 633\u2013641.","journal-title":"Lecture Notes in Computer Science"},{"key":"869_CR58","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1016\/S0895-7177(03)00133-X","volume":"37","author":"L. G. D. Pillis","year":"2003","unstructured":"Pillis, L. G. D., & Radunskaya, A. (2003). The dynamics of an optimally controlled tumor model: A case study. Mathematical and Computer Modelling, 37, 1221\u20131244.","journal-title":"Mathematical and Computer Modelling"},{"issue":"1","key":"869_CR59","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.mbs.2006.05.003","volume":"209","author":"L. G. D. Pillis","year":"2007","unstructured":"Pillis, L. G. D., Gu, W., Fister, K. R., Head, T., Maples, K., Murugan, A. et al. (2007). Chemotherapy for tumors: An analysis of the dynamics and a study of quadratic and linear optimal controls. Mathematical Biosciences, 209(1), 292\u2013315.","journal-title":"Mathematical Biosciences"},{"key":"869_CR60","volume-title":"The mathematical theory of optimal processes","author":"L. S. Pontryagin","year":"1962","unstructured":"Pontryagin, L. S., Boltyanskii, V. G., Gamkrelidze, R. V., & Mishchenko, E. F. (1962). The mathematical theory of optimal processes. New York: Gordon & Breach."},{"key":"869_CR61","doi-asserted-by":"crossref","DOI":"10.1002\/9780470182963","volume-title":"Approximate dynamic programming: Solving the curses of dimensionality","author":"W. B. Powell","year":"2007","unstructured":"Powell, W. B. (2007). Approximate dynamic programming: Solving the curses of dimensionality. Hoboken: Wiley."},{"issue":"2","key":"869_CR62","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1023\/A:1005849301420","volume":"45","author":"M. W. Retsky","year":"1997","unstructured":"Retsky, M. W., Demicheli, R., Swartzendruber, D. E., Bame, P. D., Wardwell, R. H., Bonadonna, G. et al. (1997). Computer simulation of a breast cancer metastasis model. Breast Cancer Research and Treatment, 45(2), 193\u2013202.","journal-title":"Breast Cancer Research and Treatment"},{"issue":"4","key":"869_CR63","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1056\/NEJMp048143","volume":"351","author":"D. Schrag","year":"2004","unstructured":"Schrag, D. (2004). The price tag on progress\u2014chemotherapy for colorectal cancer. New England Journal of Medicine, 351(4), 317\u2013319.","journal-title":"New England Journal of Medicine"},{"key":"869_CR64","first-page":"205","volume":"1","author":"H. E. Skipper","year":"1979","unstructured":"Skipper, H. E., Schabel, F. M., & Lloyd, H. (1979). Dose-response and tumor cell repopulation rate in chemotherapeutic trials. Advances in Cancer Chemotherapy, 1, 205\u2013253.","journal-title":"Advances in Cancer Chemotherapy"},{"issue":"7","key":"869_CR65","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1172\/JCI106971","volume":"51","author":"P. W. Sullivan","year":"1972","unstructured":"Sullivan, P. W., & Salmon, S. E. (1972). Kinetics of tumor growth and regression in IgG multiple myeloma. The Journal of Clinical Investigation, 51(7), 1697\u20131708.","journal-title":"The Journal of Clinical Investigation"},{"key":"869_CR66","volume-title":"Applications of the optimal control theory in biomedicine","author":"G. W. Swan","year":"1984","unstructured":"Swan, G. W. (1984). Applications of the optimal control theory in biomedicine. New York: Dekker."},{"key":"869_CR67","first-page":"91","volume-title":"Cancer modeling","author":"G. W. Swan","year":"1987","unstructured":"Swan, G. W. (1987). Tumor growth models and cancer chemotherapy. In J. R. Thompson & B. Brown (Eds.), Cancer modeling (pp. 91\u2013179). New York: Dekker."},{"issue":"2","key":"869_CR68","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/0025-5564(90)90021-P","volume":"101","author":"G. W. Swan","year":"1990","unstructured":"Swan, G. W. (1990). Role of optimal control theory in cancer chemotherapy. Mathematical Biosciences, 101(2), 237\u2013284.","journal-title":"Mathematical Biosciences"},{"issue":"3","key":"869_CR69","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/BF02462912","volume":"39","author":"G. W. Swan","year":"1977","unstructured":"Swan, G. W., & Vincent, T. L. (1977). Optimal control analysis in the chemotherapy of IgG multiple myeloma. Bulletin of Mathematical Biology, 39(3), 317\u2013337.","journal-title":"Bulletin of Mathematical Biology"},{"issue":"2","key":"869_CR70","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0933-3657(02)00014-3","volume":"25","author":"K. C. Tan","year":"2002","unstructured":"Tan, K. C., Khor, E. F., Cai, J., Heng, C. M., & Lee, T. H. (2002). Automating the drug scheduling of cancer chemotherapy via evolutionary computation. Artificial Intelligence in Medicine, 25(2), 169\u2013185.","journal-title":"Artificial Intelligence in Medicine"},{"issue":"1","key":"869_CR71","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1109\/TSMCB.2006.883265","volume":"37","author":"S. M. Tse","year":"2007","unstructured":"Tse, S. M., Liang, Y., Leung, K.-S., Lee, K.-H., & Mok, T. S. K. (2007). A memetic algorithm for multiple-drug cancer chemotherapy schedule optimization. IEEE Transactions on Systems, Man, and Cybernetics, Part B: Cybernetics, 37(1), 84\u201391.","journal-title":"IEEE Transactions on Systems, Man, and Cybernetics, Part B: Cybernetics"},{"key":"869_CR72","unstructured":"U.S. Department of Health and Human Services Centers for Medicare and Medicaid Services (SCMMS) (1960\u20132007). National health expenditures by type of service and source of funds, calendar years 2007\u20131960. http:\/\/www.cms.hhs.gov\/NationalHealthExpendData\/02_NationalHealthAccountsHistorical.asp#TopOfPage.Social . Accessed 7 Oct 2009."},{"issue":"6","key":"869_CR73","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1109\/TEVC.2004.834154","volume":"8","author":"M. Villasana","year":"2004","unstructured":"Villasana, M., & Ochoa, G. (2004). Heuristic design of cancer chemotherapies. IEEE Transactions on Evolutionary Computation, 8(6), 513\u2013521.","journal-title":"IEEE Transactions on Evolutionary Computation"},{"issue":"5","key":"869_CR74","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1007\/BF00932849","volume":"14","author":"P. L. Yu","year":"1974","unstructured":"Yu, P. L., & Leitmann, G. (1974). Nondominated decisions and cone convexity in dynamic multicriteria decision problems. Journal of Optimization Theory and Applications, 14(5), 573\u2013584.","journal-title":"Journal of Optimization Theory and Applications"},{"issue":"3","key":"869_CR75","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/0010-4809(80)90023-3","volume":"13","author":"S. Zietz","year":"1980","unstructured":"Zietz, S., Desaive, C., Grattarola, M., & Nicolini, C. (1980). Modeling to determine dose dependence of drug and cell kinetic parameters. Computers & Biomedical Research, 13(3), 297\u2013305.","journal-title":"Computers & Biomedical Research"},{"issue":"3","key":"869_CR76","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/BF02460814","volume":"41","author":"S. Zietz","year":"1979","unstructured":"Zietz, S., & Nicolini, C. (1979). Mathematical approaches to optimization of cancer chemotherapy. Bulletin of Mathematical Biology, 41(3), 305\u2013324.","journal-title":"Bulletin of Mathematical Biology"},{"key":"869_CR77","unstructured":"Zitzler, E. (1999). Evolutionary algorithms for multi-objective optimization: Methods and applications. Swiss Federal Institute of Technology, Zurich."}],"container-title":["Annals of Operations Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10479-011-0869-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10479-011-0869-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10479-011-0869-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,9]],"date-time":"2019-06-09T10:48:59Z","timestamp":1560077339000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10479-011-0869-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,3,31]]},"references-count":77,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,10]]}},"alternative-id":["869"],"URL":"https:\/\/doi.org\/10.1007\/s10479-011-0869-4","relation":{},"ISSN":["0254-5330","1572-9338"],"issn-type":[{"value":"0254-5330","type":"print"},{"value":"1572-9338","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,3,31]]}}}